Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature

Clinical Rheumatology

Volumn 33, Issue 11, 2014, Pages 1681-1684

  Campanilho Marques, Raquel ^a,b   Brogan, Paul A ^b  

^a Rheumatology Department Lisbon Academic Medical Centre   (Portugal)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anakinra; Hyper IgD syndrome; Mevalonate kinase deficiency; Remission

Indexed keywords

ACICLOVIR; C REACTIVE PROTEIN; IBUPROFEN; IMMUNOGLOBULIN A; PARACETAMOL; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIINFLAMMATORY AGENT; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

CASE REPORT; CERVICAL LYMPHADENOPATHY; CHILD; DRUG DOSE INCREASE; DRUG DOSE TITRATION; FEMALE; FEVER; GENETIC SCREENING; HERPES ZOSTER; HUMAN; IRON DEFICIENCY ANEMIA; LYMPHADENOPATHY; MEVALONATE KINASE DEFICIENCY; MOUTH ULCER; QUALITY OF LIFE; RASH; RESPIRATORY DISTRESS; REVIEW; RIGOR; THROMBOCYTOSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; PRESCHOOL CHILD; SIBLING;

ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MEVALONATE KINASE DEFICIENCY; SIBLINGS; TREATMENT OUTCOME;

EID: 84919402945     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2523-4     Document Type: Review

References (19)

1. Shendi HM, Walsh D, Edgar JD (2012) Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatol Int 32:249–251
2. Prietsch V, Mayatepek E, Krastel H, Haas D, Zundel D, Waterham HR, Wanders RJ, Gibson KM, Hoffman GF (2003) Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum. Paediatrics 111:258–261
3. Drenth JPH, Cuisset L, Grateau G et al (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. Nat Genet 22:178–181
4. Stankovic K, Grateau G (2007) Auto inflammatory syndromes: diagnosis and treatment. Joint Bone Spine 74:544–550
5. Gattorno M, Federici S, Pelagatti MA et al (2008) Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol 28(S1):S73–S83
6. Drenth JPH, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinaemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International hyper-IgD study group. Medicine 73:133–144
7. van der Hilst JC, Bodar EJ, Barron KS et al (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulin D syndrome. Medicine 87:301–310
8. Bader-Meunier B, Florkin B, Sibilia J et al (2011) Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 28:e152–e159
9. Simon A, Drewe E, van der Meer JW et al (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483
10. Frenkel J, Rijkers GT, Mandey SH et al (2002) Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 46:2794–2803
11. Houten SM, Frenkel J, Waterham HR (2003) Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation. Cell Mol Life Sci 60:1118–1134
12. van der Hilst JC, Frenkel J (2010) Hyperimmunoglobulin D syndrome in childhood. Curr Rheumatol Rep 12:101–107
13. Mandey SH, Kuijk LM, Frenkel J, Waterham HR (2006) A role for geranylgeranylation in interleukin-1beta secretion. Arthritis Rheum 54:3690–3695
14. Kuijk LM, Mandey SH, Schellens I et al (2008) Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1. Mol Immunol 45:2158–2165
15. Kuijk LM, Beekman JM, Koster J et al (2008) HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation. Blood 112:3563–3573
16. Normand S, Massonnet B, Delwail A et al (2009) Specific increase in caspase-1 activity and secretion of IL-1 family cytokines: a putative link between mevalonate kinase deficiency and inflammation. Eur Cytokine Netw 20:101–107
17. Ter Haar N, Lachmann H, Özen S et al (2013) Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis 72:678–685
18. Galeotti C, Meinzer U, Quartier P et al (2012) Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. Rheumatology 51:1855–1859
19. Bodar EJ, Kuijk LM, Drenth JPH et al (2011) On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis 70:2155–2158